Cardiovascular risk assessment: are we getting all the information we need?

Competing Interests: Conflict of interest: A.P. has nothing to disclose; A.L.C. has received honoraria, lecture fees, or research grants from Aegerion, Amgen, Amryt, AstraZeneca, Bayer, Daiichi Sankyo, Eli Lilly, Genzyme, Ionis Pharmaceutical, Kowa, Mediolanum, Medscape, Menarini, Merck, Mylan, Novartis, PeerVoice, Pfizer, Recordati, Regeneron, Sanofi, Sigma-Tau, and The Corpus, outside the submitted work. The work of A.L.C. is supported in part by Ministero della Salute Ricerca Corrente to MultiMedica IRCCS.